These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 808781)

  • 21. Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
    Koontz WW; Heney NM; Soloway MS; Kluskens L; Hazra TA; Trump DL; Barton B
    Urology; 1985 Oct; 26(4 Suppl):30-1. PubMed ID: 3931326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder cancer.
    Vera-Donoso CD; Llopis B; Oliver F; Gallego J; Ruiz J; Vidal J; Jiménez Cruz JF
    Eur Urol; 1990; 17(3):219-22. PubMed ID: 2112473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 27. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.
    Fisher HA
    Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical-experience with thiotepa in the treatment of bladder cancer].
    Gallo FJ; Menéndez-Ondina L; Matallana A; Bonilla JA; Serrano E; Carballido JA; Mendoza A
    Actas Urol Esp; 1978; 2(5):237-40. PubMed ID: 103371
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy and prevention of recurrence in bladder cancer. Convincing results].
    Urologe A; 1995 Sep; 34(5 Suppl):1-4. PubMed ID: 9131099
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A; Sauvage I; Gremillet E; Héritier P; Richard A; el Hajj E; Diez-Yanguas J
    J Urol (Paris); 1987; 93(4):197-202. PubMed ID: 3119728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign bladder papillomas, prognosis and treatment. Attempt at an anatomo-clinical correlation].
    Tuchschmid D; Luzuy R; Bouzakoura C
    Helv Chir Acta; 1973 Dec; 40(5):795-801. PubMed ID: 4203751
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G; Mellin P
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemoprophylaxis of superficial bladder tumors. Results of the EORTC study].
    Bouffioux C; Denis L; Debruyne F; Kurth KH; Schulman C
    Acta Urol Belg; 1986; 54(2):175-87. PubMed ID: 3728219
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 39. [Local chemotherapy in vesical neoplasms].
    Pavone-Macaluso M; Caramia G; Rizzo FP
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):844-8. PubMed ID: 4217830
    [No Abstract]   [Full Text] [Related]  

  • 40. [The so-called benign tumors of the urinary tract].
    Rutishauser G; Klein U
    Helv Chir Acta; 1973 Dec; 40(5):667-77. PubMed ID: 4203748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.